The calcium-sensing receptor and related diseases

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 4, 2006, Pages 628-639

  D'Souza Li, Lília ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Center for Investigation in Pediatrics (CIPED)   (Brazil)

Author keywords

Autosomal dominant hypocalcemia; Bartter syndrome type V; CASR; Familial hypocalciuric hypercalcemia; Mutations; Neonatal severe hyperparathyroidism

Indexed keywords

EID: 33751212739     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000400008     Document Type: Review

References (118)

1. 2+ and other ions as extracellular (first) messengers. Physiol Rev 1991;71(2):371-411.
2. (2+)-sensing receptor from bovine parathyroid. Nature 1993;366(6455):575-80.
3. Hauache OM. Extracellular calcium-sensing receptor: Structural and functional features and association with diseases. Braz J Med Biol Res 2001;34(5):577-84.
4. Janicic N, Soliman E, Pausova Z, Seldin MF, Riviere M, Szpirer J, et al. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mamm Genome 1995;6(11):798-801.
5. (2+)-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 1995;214(2):524-9.
6. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995;270(21):12919-25.
7. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 1992;258(5082):597-603.
8. Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997;386(6622):239-46.
9. Herrada G, Dulac C. A novel family of putative pheromone receptors in mammals with a topographically organized and sexually dimorphic distribution. Cell 1997;90(4):763-73.
10. Hoon MA, Adler E, Lindemeier J, Battey JF, Ryba NJ, Zuker CS. Putative mammalian taste receptors: A class of taste-specific GPCRs with distinct topographic selectivity. Cell 1999;96(4):541-51.
11. Wellendorph P, Hansen KB, Balsgaard A, Greenwood JR, Egebjerg J, Brauner-Osborne H. Deorphanization of GPRC6A: A promiscuous L-alpha-amino acid receptor with preference for basic amino acids. Mol Pharmacol 2005;67(3):589-97.
12. Brauner-Osborne H, Krogsgaard-Larsen P. Sequence and expression pattern of a novel human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 2000;65(2):121-8.
13. Brauner-Osborne H, Jensen AA, Sheppard PO, Brodin B, Krogsgaard-Larsen P, O'Hara P. Cloning and characterization of a human orphan family C G-protein coupled receptor GPRC5D. Biochim Biophys Acta 2001;1518(3):237-48.
14. Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 1998;273(36):23605-10.
15. Ward DT, Brown EM, Harris HW. Disulfide bonds in the extracellular calcium-polyvalent cation-sensing receptor correlate with dimer formation and its response to divalent cations in vitro. J Biol Chem 1998;273(23):14476-83.
16. Bai M, Trivedi S, Kifor O, Quinn SJ, Brown EM. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA 1999;96(6):2834-9.
17. 2+ receptor activation. Endocrine 2000;13(1):63-70.
18. o-sensing receptor. J Biol Chem 1996;271(32):19537-45.
19. Oda Y, Tu CL, Pillai S, Bikle DD. The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation. J Biol Chem 1998;273 (36):2 3344-52.
20. 2+ receptor is essential for its expression at the cell surface. Endocrinology 1997;138(5):1916-22.
21. 2+-sensing function of the metabotropic glutamate receptors. Science 1998;279(5357):1722-5.
22. (2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997;200(Pt 2):295-302.
23. Conklin BR, Bourne HR. Homeostatic signals. Marriage of the flytrap and the serpent [news]. Nature 1994;367(6458):22.
24. O'Hara PJ, Sheppard PO, Thogersen H, Venezia D, Haldeman BA, McGrane V, et al. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron 1993;11(1):41-52.
25. Brauner-Osborne H, Jensen AA, Sheppard PO, O'Hara P, Krogsgaard-Larsen P. The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain. J Biol Chem 1999;274(26):18382-6.
26. 2+ binding pocket within the Venus flytrap module of the human calcium-sensing receptor. J Biol Chem 2005;280(45):37917-23.
27. Quinn SJ, Kifor O, Trivedi S, Diaz R, Vassilev P, Brown E. Sodium and ionic strength sensing by the calcium receptor. J Biol Chem 1998;273(31):19579- 86.
28. Doroszewicz J, Waldegger P, Jeck N, Seyberth H, Waldegger S. pH dependence of extracellular calcium sensing receptor activity determined by a novel technique. Kidney Int 2005;67(1):187-92.
29. 2+ concentrations on the levels of inositol 1,3,4,5-tetrakisphosphate in bovine parathyroid cells. Endocrinology 1989;124(2):838-44.
30. 2+-sensing receptor. J Mol Endocrinol 1998;21(1):7-17.
31. Brown EM, Hebert SC. Calcium-receptor-regulated parathyroid and renal function. Bone 1997;20(4):303-9.
32. 2+-sensing receptor. J Biol Chem 1996;271(11):5972-5.
33. Emanuel RL, Adler GK, Kifor O, Quinn SJ, Fuller F, Krapcho K, et al. Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol 1996;10(5):555-65.
34. Arthur JM, Collinsworth GP, Gettys TW, Quarles LD, Raymond JR. Specific coupling of a cation-sensing receptor to G protein alpha-subunits in MDCK cells. Am J Physiol 1997;273(1 Pt 2):129-35.
35. Chattopadhyay N, Ye CP, Yamaguchi T, Vassilev PM, Brown EM. Evidence for extracellular calcium-sensing receptor mediated opening of an outward K+ channel in a human astrocytoma cell line (U87). Glia 1999;26(1):64-72.
36. Chattopadhyay N, Ye CP, Yamaguchi T, Kifor O, Vassilev PM, Nishimura R, et al. Extracellular calcium-sensing receptor in rat oligodendrocytes: Expression and potential role in regulation of cellular proliferation and an outward K+ channel. Glia 1998;24(4):449-58.
37. Chattopadhyay N, Ye C, Yamaguchi T, Nakai M, Kifor O, Vassilev PM, et al. The extracellular calcium-sensing receptor is expressed in rat microglia and modulates an outward K+ channel. J Neurochem 1999;72(5):1915-22.
38. Chattopadhyay N, Ye C, Singh DP, Kifor O, Vassilev PM, Shinohara T, et al. Expression of extracellular calcium-sensing receptor by human lens epithelial cells. Biochem Biophys Res Commun 1997;233(3):801-5.
39. McNeil SE, Hobson SA, Nipper V, Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998;273(2):1114-20.
40. Kallay E, Kifor O, Chattopadhyay N, Brown EM, Bischof MG, Peterlik M, et al. Calcium-dependent c-myc protooncogene expression and proliferation of Caco-2 cells: A role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun 1997;232(1):80-3.
41. (2+)-sensing receptor messenger ribonucleic acid and protein. Endocrinology 1995;136(7):3087-92.
42. Hebert SC. Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney. Kidney Int 1996;50(6):2129-39.
43. Chattopadhyay N, Baum M, Bai M, Riccardi D, Hebert SC, Harris HW, et al. Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 1996;271(3 Pt 2):736-43.
44. Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol 1989;256(2 Pt 2):197-210.
45. 2+-inhibitable adenylyl cyclases along the renal tubule. Functional consequences for regulation of the cAMP content. J Biol Chem 1996;271(32):19264-71.
46. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997;99(6):1399-405.
47. 2+. J Biol Chem 1998;273(24):15192-202.
48. Attie MF, Gill JR Jr., Stock JL, Spiegel AM, Downs RW Jr., Levine MA, et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 1983;72(2):667-76.
49. Bikle DD, Ratnam A, Mauro T, Harris J, Pillai S. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 1996;97(4):1085-93.
50. (2+) and 1,25-dihydroxyvitamin D(3). Cancer Res 2005;65(2):493-8.
51. Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, et al. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 1998;249(2):325-31.
52. (o) on the function of ST2 cells. Endocrinology 1998;139(8):3561-8.
53. o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem Biophys Res Commun 1998;243(3):753-7.
54. Kameda T, Mano H, Yamada Y, Takai H, Amizuka N, Kobori M, et al. Calcium-sensing receptor in mature osteoclasts, which are bone-resorbing cells. Biochem Biophys Res Commun 1998;245(2):419-22.
55. 2+ sensing. J Clin Invest 1995;96(3):1582-90.
56. Quarles LD, Hartle JE2, Siddhanti SR, Guo R, Hinson TK. A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor. J Bone Miner Res 1997;12(3):393-402.
57. Ferry S, Chatel B, Dodd RH, Lair C, Gully D, Maffrand JP, et al. Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary tumor cells. Biochem Biophys Res Commun 1997;238(3):866-73.
58. Van Den Hurk MJ, Jenks BG, Roubos EW, Scheenen WJ. The extracellular calcium-sensing receptor increases the number of calcium steps and action currents in pituitary melanotrope cells. Neurosci Lett 2005;377(2):125-9.
59. Kato M, Doi R, Imamura M, Furutani M, Hosotani R, Shimada Y. Calcium-evoked insulin release from insulinoma cells is mediated via calcium-sensing receptor. Surgery 1997;122(6):1203-11.
60. Canaff L, Petit JL, Kisiel M, Watson PH, Gascon-Barre M, Hendy GN. Extracellular calcium-sensing receptor is expressed in rat hepatocytes coupling to intracellular calcium mobilization and stimulation of bile flow. J Biol Chem 2001;276(6):4070-9.
61. Ray JM, Squires PE, Curtis SB, Meloche MR, Buchan AM. Expression of the calcium-sensing receptor on human antral gastrin cells in culture. J Clin Invest 1997;99(10):2328-33.
62. Foley TP Jr., Harrison HC, Arnaud CD, Harrison HE. Familial benign hypercalcemia. J Pediatr 1972;81(6):1060-7.
63. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs RW Jr., Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: Clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981;60(6):397-412.
64. Law WM Jr., Heath HD. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 1985;102(4):511-9.
65. Pidasheva S, Canaff L, Simonds WF, Marx SJ, Hendy GN. Impaired co-translational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia. Hum Mol Genet 2005;14(12):1679-90.
66. Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S, et al. Genetic testing in familial isolated hyperparathyroidism: Unexpected results and their implications. J Med Genet 2004;41(3):155-60.
67. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000;16(4):281-96.
68. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994;93(3):1108-12.
69. Chou YH, Brown EM, Levi T, Crowe G, Atkinson AB, Arnqvist HJ, et al. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1992;1(4):295-300.
70. (2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75(7):1297-303.
71. (2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 1995;56(5):1075-9.
72. Heath HD, Jackson CE, Otterud B, Leppert MF. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: Evidence for locus heterogeneity. Am J Hum Genet 1993;53(1):193-200.
73. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 1999;64(1):189-95.
74. Brown EM. Editorial: Mutant extracellular calcium-sensing receptors and severity of disease. J Clin Endocrinol Metab 2005;90(2):1246-8.
75. Spiegel AM. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996;81(7):2434-42.
76. Pratt EL, Geren BB, Neuhauser EBD. Hypercalcemia and idiopathic hyperplasia of parathyroid glands in an infant. J Pediat 1947;30:388-99.
77. Philips R. Primary diffuse parathyroid hyperplasia in an infant of four months. Pediatrics 1948;2:428-34.
78. Pearce SH, Bai M, Quinn SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996;98(8):1860-6.
79. 2+-sensing receptor gene: Normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997;99(1):88-96.
80. Marx SJ, Fraser D, Rapoport A. Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. Am J Med 1985;78(1):15-22.
81. Harris SS, D'Ercole AJ. Neonatal hyperparathyroidism: The natural course in the absence of surgical intervention. Pediatrics 1989;83(1):53-6.
82. (2+)-sensing receptor gene. J Clin Endocrinol Metab 1995;80(9):2594-8.
83. Winter WE, Silverstein JH, Maclaren NK, Riley WJ, Chiaro JJ. Autosomal dominant hypoparathyroidism with variable, age-dependent severity. J Pediatr 1983;103(3):387-90.
84. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996;335(15):1115-22.
85. Finegold DN, Armitage MM, Galiani M, Matise TC, Pandian MR, Perry YM, et al. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatr Res 1994;36(3):414-7.
86. (2+)-sensing receptor gene mutation. Nat Genet 1994;8(3):303-7.
87. Heath D. Familial hypocalcemia - not hypoparathyroidism. N Engl J Med 1996;335(15):1144-5.
88. Sato K, Hasegawa Y, Nakae J, Nanao K, Takahashi I, Tajima T, et al. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 2002;87(7):3068-73.
89. Mittelman SD, Hendy GN, Fefferman RA, Canaff L, Mosesova I, Cole DE, et al. A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: Successful treatment with recombinant human parathyroid hormone. J Clin Endocrinol Metab 2006;91(7):2474-9.
90. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002;13(9):2259-66.
91. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002;360(9334):692-4.
92. 2+ receptor. FEBS Lett 1999;448(1):180-4.
93. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322(26):1829-36.
94. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996;97(4):910-4.
95. Pallais JC, Kifor O, Chen YB, Slovik D, Brown EM. Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor. N Engl J Med 2004;351(4):362-9.
96. Pidasheva S, D'Souza-Li L, Canaff L, Cole DE, Hendy GN. CASRdb: Calcium-sensing receptor locus-specific database for mutations causing familial (benign) hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2004;24(2):107-11.
97. 2+. J Biol Chem 2005;280(6):5113-20.
98. D'Souza-Li L, Yang B, Canaff L, Bai M, Hanley DA, Bastepe M, et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002;87(3):1309-18.
99. Lienhardt A, Garabedian M, Bai M, Sinding C, Zhang Z, Lagarde JP, et al. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2000;85(4):1695-702.
100. Zhang M, Breitwieser GE. High affinity interaction with filamin A protects against calcium-sensing receptor degradation. J Biol Chem 2005;280(12):11140-6.
101. Huang Y, Niwa JI, Sobue G, Breitwieser GE. Calcium sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin. J Biol Chem 2006.
102. (2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995;56(4):880-6.
103. D'Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 2001;18(5):411-21.
104. Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995;96(6):2683-92.
105. (2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet 1996;98(2):129-33.
106. (2+)-sensing receptor gene in Japanese individuals: No relation to non-insulin dependent diabetes mellitus. Horm Metab Res 1996;28(10):541-4.
107. Mutational analysis of the extracellular calcium-sensing receptor gene in human parathyroid tumors. 1997;97.
108. Cetani F, Pinchera A, Pardi E, Cianferotti L, Vignali E, Picone A, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas [In Process Citation]. J Bone Miner Res 1999;14 (6):878-82.
109. (2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996;5 (5):601-6.
110. Scillitani A, Guarnieri V, De Geronimo S, Muscarella LA, Battista C, D'Agruma L, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab 2004;89(11):5634-8.
111. Cole DE, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations [see comments]. Lancet 1999;353(9147):112-5.
112. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 1998;95(7):4040-5.
113. (2+) for drug development: The extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics. J Pharmacol Sci 2005;97(3):355-60.
114. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568. Mol Pharmacol 1998;53(6):1083-8.
115. 2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 2004;279(18):18990-7.
116. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350(15):1516-25.
117. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 2001;299(1):323-31.
118. Arey BJ, Seethala R, Ma Z, Fura A, Morin J, Swartz J, et al. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo. Endocrinology 2005;146(4):2015-22.